CTLA4 and cancer: Anti-programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) immunotherapies are commonly used in the treatment of various cancers [28, 29].